Pharma Journalist -

LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of a broader contract development and manufacturing organization (CDMO)…
Read More...

Excalipoint Therapeutics has secured an oversubscribed $68.7 million seed financing round to accelerate the development of its next-generation T-cell engager (TCE) therapies, marking…
Read More...

The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) have unveiled a new collaborative framework aimed at speeding…
Read More...

Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an investigational oral therapy designed to treat hormone receptor-positive,…
Read More...

Another major milestone has reshaped the T‑cell engager landscape. Vir Biotechnology and Astellas Pharma have entered a new global strategic partnership valued at $1.71 billion to…
Read More...

Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE™ (icotrokinra), a novel oral therapy for the treatment of moderate-to-severe…
Read More...

Voro Therapeutics has entered into a research collaboration with Daiichi Sankyo to develop next-generation antibody-drug conjugates (ADCs) using its proprietary PrimeBody platform. The…
Read More...

Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio Therapeutics Inc. to advance the manufacturing of regulatory T-cell (Treg)…
Read More...

R1 Therapeutics has officially launched as a new clinical-stage biopharmaceutical company, backed by an oversubscribed $77.5 million Series A financing and a strategic licensing…
Read More...

Sun Pharmaceutical Industries Limited has announced that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental Biologics License Application (sBLA) for…
Read More...